Evaluation of Commercially Available Anti–Dengue Virus Immunoglobulin M Tests
Elizabeth A. Hunsperger, Sutee Yoksan, Philippe Buchy, Vinh Chau Nguyen, Shamala D. Sekaran, Delia A. Enria, Jose L. Pelegrino, Susana Vázquez, Harvey Artsob, Michael Drebot, Duane J. Gubler, Scott B. Halstead, María G. Guzmán, Harold S. Margolis, Carl-Michael Nathanson, Nidia R. Rizzo Lic, Kovi E. Bessoff, Srisakul Kliks, and Rosanna W. Peeling
Author affiliations: Centers for Disease Control and Prevention, San Juan, Puerto Rico, USA (E.A. Hunsperger, K.E. Bessoff); Mahidol University, Bangkok, Thailand (S. Yoksan); Institut Pasteur, Phnom Penh, Cambodia (P. Buchy); Cho Quan Hospital, Ho Chi Minh City, Vietnam (V.C. Nguyen); University of Malaya, Kuala Lumpur, Malaysia (S.D. Sekaran); Instituto Nacional Enfermedades Virales Humanas Dr. Julio I. Maiztegui, Buenos Aires, Argentina (D.A. Enria); Instituto Medicina Tropical Pedro Kouri, Havana, Cuba (S. Vázquez, M.G. Guzmán, J.L. Pelegrino); Public Health Agency of Canada, Winnipeg, Manitoba, Canada (H. Artsob, M. Drebot); University of Hawaii, Honolulu, Hawaii, USA (D.J. Gubler); Pediatric Dengue Vaccine Initiative, Seoul, South Korea (S.B. Halstead, H.S. Margolis, S. Kliks); World Health Organization, Geneva, Switzerland (C.-M. Nathanson, N.R. Rizzo, R.W. Peeling)
Main Article
Table 1
Panels used for evaluation of 350 serum samples from patients with positive and negative results for IgM to DENV*
Evaluation panel |
No. samples |
DENV IgM positive |
|
From primary infections |
27 |
From secondary infections |
154 |
Total positive
|
181†
|
DENV IgM negative |
|
DENV positive/DENV IgM negative |
19 |
DENV IgG positive
|
7
|
Related flavivirus IgM positive |
|
West Nile virus positive |
25 |
Yellow fever virus positive
|
4
|
Related flavivirus IgG positive |
|
West Nile virus positive |
1 |
Yellow fever virus positive |
10 |
St. Louis encephalitis virus positive |
2 |
Japanese encephalitis virus positive
|
10
|
Febrile illness |
|
Lyme disease IgG positive |
9 |
Malaria |
31 |
New World hantavirus IgM positive
|
7
|
Systemic conditions |
|
Rheumatoid factor |
6 |
Systemic lupus erythematosus
|
2
|
Healthy persons‡ |
|
Negative
|
36
|
Total negative |
169 |
Main Article
Page created: December 07, 2010
Page updated: December 07, 2010
Page reviewed: December 07, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.